Patent Assignment
Reel/Frame 033948/0960
Change of Name
Recorded: 2014-10-09
Pages: 6
Assignor
MEDIMMUNE, INC.
Executed: 2008-03-25
Assignee
MEDIMMUNE, LLC
ONE MEDIMMUNE WAY, GAITHERSBURG, MARYLAND, 20878
Covered Property
(1)
Humanized Anti-CD19 Antibodies and Their Use in Treatment of Oncology, Transplantation and Autoimmune Disease
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 9, 2014
From: DAMSCHRODER, MELISSA; KIENER, PETER; WU, HERREN; DALL'ACQUA, WILLIAM
To: MEDIMMUNE, INC.
Reel/Frame 033948/0928 →
Assignment of Assignor's Interest
Apr 20, 2018
From: MEDIMMUNE, LLC
To: VIELA BIO, INC.
Reel/Frame 045604/0693 →
Security Agreement
Mar 15, 2021
From: HORIZON ORPHAN LLC; HORIZON THERAPEUTICS USA, INC.; VIELA BIO, INC.
To: CITIBANK, N.A.
Reel/Frame 055659/0430 →
Release of Security Interest
Oct 6, 2023
From: CITIBANK, N.A.
To: HORIZON THERAPEUTICS U.S. HOLDING LLC (FKA HORIZON ORPHAN LLC); HORIZON THERAPEUTICS USA, INC.; VIELA BIO, INC.
Reel/Frame 065154/0064 →